NCT07703449

Brief Summary

Low vision substantially impairs reading ability and educational participation in adolescents. Existing assistive technologies, including optical magnifiers and electronic visual aids, are often limited by fragmented system architectures and insufficient support for multimodal cognitive processing. This study aimed to develop and evaluate a virtual reality (VR)-based intelligent reading aid integrating image enhancement, optical character recognition (OCR), text-to-speech (TTS), and large language model (LLM)-based semantic summarization for low-vision users.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2026

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
Last Updated

July 14, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

June 15, 2026

Last Update Submit

July 12, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Phoria

    Variation of ocular phoria before and after single-session VR intelligent reading aid use, to evaluate the impact of near-eye VR optical system on adult eye position stability.

    within 10 minutes after all reading tasks

  • Reading Completion Time

    Time to finish standardized 100-character Chinese reading tasks (unit: second). Compare results between unaided and VR-assisted conditions.

    within 10 minutes after all reading tasks

Secondary Outcomes (6)

  • Tear Break-Up Time (TBUT)

    within 10 minutes after all reading tasks

  • Accommodative Function

    within 10 minutes after all reading tasks

  • Simulator Sickness Questionnaire (SSQ)

    within 10 minutes after all reading tasks

  • Best-Corrected Visual Acuity (BCVA)

    within 10 minutes after all reading tasks

  • Intraocular Pressure (IOP)

    within 10 minutes after all reading tasks

  • +1 more secondary outcomes

Study Arms (2)

Baseline: Unaided Reading

EXPERIMENTAL

Arm Name:Unaided Reading (Baseline) Arm Type:Active Comparator Intervention Type:Device Intervention Name:Natural Vision Reading (No Assistive Device) Intervention Description: Participants complete standardized Chinese reading tasks relying on natural vision without any visual aid. Each task contains 100 Chinese characters. Reading performance and user satisfaction are evaluated.

Device: VR-Based Intelligent Reading Aid

Experimental: VR-Assisted Reading

EXPERIMENTAL

Arm Name:VR-Based Intelligent Reading Aid Arm Type:Experimental Intervention Type:Device Intervention Name:VR-Based Multimodal Intelligent Reading Aid (Langshiqing Low-Vision Device) Intervention Description: Participants use the VR head-mounted intelligent reading aid to complete the same standardized reading tasks. The device integrates image enhancement, OCR, text-to-speech (TTS) and LLM-based semantic summarization. The test luminance is set at 400 nit (maximum recommended brightness). Each task contains 100 Chinese characters. Duration:Single session, approximately 5 minutes

Device: Natural Vision Reading (No Assistive Device)

Interventions

Intervention Description: Participants use the VR head-mounted intelligent reading aid to complete the same standardized reading tasks. The device integrates image enhancement, OCR, text-to-speech (TTS) and LLM-based semantic summarization. The test luminance is set at 400 nit (maximum recommended brightness). Each task contains 100 Chinese characters. Duration:Single session, approximately 5 minutes

Baseline: Unaided Reading

Participants complete reading tasks with natural vision, without using any assistive device.

Experimental: VR-Assisted Reading

Eligibility Criteria

Age9 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Healthy adult volunteers aged 18-40 years
  • Best-corrected binocular visual acuity of 0.8 or better
  • Stereopsis of 60 arcsec or better
  • Tear film break-up time of at least 10 seconds,Horizontal phoria within 15 prism diopters at both distance and near,Spherical equivalent refractive errors between plano and -6.00 D,Astigmatism not exceeding 3.00 D,Anisometropia not exceeding 2.00 D
  • Intraocular pressure between 10 and 21 mmHg
  • All participants provided written informed consent before enrollment

You may not qualify if:

  • Any current or previous organic ocular disease (such as keratitis, glaucoma, or retinal detachment)
  • Previous ophthalmic surgery (including refractive surgery or vitreoretinal surgery)
  • Systemic or psychiatric disorders that could affect study participation
  • Inability or unwillingness to complete the examination procedures
  • Functional Evaluation Cohort:
  • Aged 9-17 years
  • Sufficient basic reading ability to complete the experimental tasks
  • Written informed consent obtained from all participants and their legal guardians prior to participation
  • Systemic or psychiatric disorders affecting participation
  • Inability or unwillingness to complete the examination procedures Functional Evaluation Cohort

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Specialized School for Visually Impaired Students in Guangdong Province

Guangzhou, Guangdong, 510060, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chief Physician

Study Record Dates

First Submitted

June 15, 2026

First Posted

July 14, 2026

Study Start

June 15, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 14, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations